Health
SARS-CoV-2 can disrupt the blood-brain barrier, find scientists – Drug Target Review
Binding of SARS-CoV-2 spike proteins to the brain’s endothelial cells could be the cause the neurological symptoms associated with COVID-19.
Posted: 2 November 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Binding of SARS-CoV-2 spike proteins to the brains endothelial cells can cause the blood-brain barrier to become leaky, potentially causing the neurological symptoms associated with COVID-19.
While the causes of respiratory symptoms related to SARS-CoV-2 infection have been well studied, the vascular and neurological symptoms are more poorly understood.
In the case of respiratory symptoms, it is known that entry of the…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General13 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News22 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General13 hours agoOf saints and sinners | The Spectator Australia